4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-005780
Chief Executive Officer acquired 171,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil Chief Executive Officer | 2020-01-29 | Grant or award | +171,700 | 1,904,973 | D | ||
| Derivatives | |||||||
| Cooper Laurence James Neil Chief Executive Officer | 2020-01-29 | Grant or award · Employee Stock Option (right to buy) | +264,200 | 264,200 | D | ||
Loading xslF345X03/doc4.xml…